Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A composite model for HERG blockade.

Christian Kramer1, Bernd Beck, Jan M Kriegl

  • 1Department of Lead Discovery, Boehringer-Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.

Chemmedchem
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026
Same author

Trapped Cycloadducts of 1-Azabutadienes via Microwave-Assisted Ring Opening of <i>N</i>-Acyl-2-azetines.

The Journal of organic chemistry·2026
Same author

The Myth of "Anti-Electrostatic" Bonds.

Journal of computational chemistry·2026
Same author

Activation volumes associated with excited-state electron transfer across amidinium-carboxylate bridge.

Chemical science·2026
Same author

The Common Fund Data Ecosystem (CFDE).

bioRxiv : the preprint server for biology·2026
Same author

Subporphyrazine scaffolds as emerging electron acceptors for long-lived charge separation.

Chemical science·2026
Same journal

Metal-Drug Complexes as Long-Release Application for Antimalarial PfFNT-Inhibitors.

ChemMedChem·2026
Same journal

Speciation Studies of Monosubstituted Pt, Mo, and W Decavanadates in Culture Media and In Vitro Activity Against Trypanosoma cruzi.

ChemMedChem·2026
Same journal

Novel Xanthene Derivatives for Neuroprotection in Alzheimer's Disease-Synthesis and Biological Assessment.

ChemMedChem·2026
Same journal

Discovery of a New Scaffold RSK2 Inhibitor With Virtual and Phenotypical Screening.

ChemMedChem·2026
Same journal

Levoglucosenone-Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry.

ChemMedChem·2026
Same journal

Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs.

ChemMedChem·2026
See all related articles

Predictive QSAR models can identify hERG channel blockers, differentiating specific and nonspecific binding. This approach aids in optimizing drug leads by reducing costly experimental testing for hERG toxicity.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Toxicology

Background:

  • hERG channel blockade is a significant toxicological concern during drug development.
  • Experimental methods like patch-clamp assays are costly and time-consuming.
  • Lack of crystal structures for hERG channels limits traditional structure-based drug design.

Purpose of the Study:

  • To develop reliable ligand-based in silico models for predicting hERG channel blockade.
  • To differentiate between specific and nonspecific binding mechanisms of hERG blockers.
  • To accelerate lead structure optimization by reducing reliance on expensive experimental validation.

Main Methods:

  • Development of Quantitative Structure-Activity Relationship (QSAR) models.
  • Pharmacophore scanning to identify potential specific binders.

Related Experiment Videos

  • Application of Partial Least Squares (PLS) and Support Vector Regression (SVR) models.
  • Utilized quantum mechanically derived descriptors on a literature dataset of 113 molecules.

    • Main Results:

    • QSAR models achieved R(2) values between 0.60 and 0.70 for independent validation sets.
    • Models showed varying performance (R(2) 0.39-0.76) when partitioned by pharmacophore search for test sets.
    • The study successfully differentiated between specific and nonspecific hERG binding.

    Conclusions:

    • hERG blockade can result from diverse binding interactions.
    • Multiple predictive models may be required for comprehensive assessment of hERG toxicity.
    • In silico QSAR models offer a valuable tool for predicting hERG blockade during drug discovery.